Saxagliptin

• Class of medications: Dipeptidyl peptidase-4 (DPP-4) inhibitors
• Weight neutral with low risk of hypoglycemia.
• Demonstrates a statistically significant and clinically meaningful improvement in glycemic control.
• More efficacious and have a better safety profile than acarbose and sulfonylurea.
• Efficiently lowers FPG (fasting plasma glucose) and PPG (Postprandial glucose levels in combination therapy with metformin.